Jupiter Life Line Hospitals Ltd. has announced a series of strategic developments, reinforcing its growth trajectory and operational strength as one of Western India’s leading healthcare providers.
Key Highlights:
-
Leadership Appointments: The board has appointed Sivasish Sen as Chief Financial Officer (CFO), effective May 12, 2025. Additionally, Ankit Thakker has been elevated to Joint Managing Director and CEO, reflecting the company’s commitment to experienced leadership as it scales operations and expands its hospital network.
-
Amalgamation with Medulla Healthcare: The board has approved the merger of Medulla Healthcare Private Limited with Jupiter Life Line Hospitals. This strategic move will further consolidate Jupiter’s presence in the Mumbai region, leveraging Medulla’s assets and expertise to enhance service offerings and operational synergies.
-
Dividend Declaration: The board has recommended a final dividend of ₹1 per equity share for FY 2024-25, rewarding shareholders for their continued support. The dividend is subject to shareholder approval at the upcoming AGM.
-
Strong Q4 Financial Performance: For the March quarter, Jupiter Life Line Hospitals reported consolidated revenue from operations of ₹3.27 billion and a net profit of ₹448.7 million. The company continues to deliver healthy growth, driven by high occupancy rates, increased average revenue per occupied bed (ARPOB), and expansion in key markets.
-
Growth Outlook: Jupiter Life Line Hospitals remains debt-free, with significant cash reserves, and is actively expanding its capacity with new hospitals in Dombivli and South Pune. The company aims to reach 2,200 beds soon and is targeting further expansion to 2,500 beds in the near future
These developments underscore Jupiter’s focus on leadership excellence, strategic consolidation, shareholder value, and sustained growth in India’s healthcare sector.
Sources: Jupiter Life Line Hospitals Annual Report, JM Financial, Tickertape, BSE, Company Filings